KUALA LUMPUR, Feb 3 (Bernama) -- Zenas BioPharma Inc, a clinical-stage global biopharmaceutical company, has announced its management team will present in a fireside chat at the Guggenheim SMID Cap Biotech Conference on Feb 5.
According to a statement, the presentation will be available via a live webcast, and an archived replay can be accessed under the "Events and Presentations" section of the Investor & Media Relations page on the Zenas BioPharma website.
Zenas is committed to becoming a leader in the development and commercialisation of transformative immunology-based therapies, aiming to improve the lives of those facing autoimmune and rare diseases.
-- BERNAMA
BERNAMA provides up-to-date authentic and comprehensive news and information which are disseminated via BERNAMA Wires; www.bernama.com; BERNAMA TV on Astro 502, unifi TV 631 and MYTV 121 channels and BERNAMA Radio on FM93.9 (Klang Valley), FM107.5 (Johor Bahru), FM107.9 (Kota Kinabalu) and FM100.9 (Kuching) frequencies.
Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter : @bernama.com, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial
